miércoles, 7 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 19, 2026

Procter & Gamble Q2 Earnings Preview: Buy Now or Stay Cautious?

View original at finance.yahoo.com
Procter & Gamble Q2 Earnings Preview: Buy Now or Stay Cautious? The Procter & Gamble Company PG, also known as P&G, is set to report second-quarter fiscal 2026 results on Jan…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • For new investors, waiting for clearer signs of margin recovery or a more attractive valuation could be prudent

    80% confidence
  • Existing shareholders may consider holding the stock for its stability and long-term fundamentals, while closely monitoring execution on innovation, pricing and productivity initiatives

    80% confidence
  • PG has a trailing four-quarter earnings surprise of 2.3%, on average

    80% confidence
  • Management expects higher costs from tariffs of $400 million, after-tax, for fiscal 2026

    80% confidence
  • The Zacks Consensus Estimate for fiscal second-quarter revenues is pegged at $22.23 billion, indicating a 1.6% rise from the prior-year quarter's reported figure

    80% confidence
  • Management acknowledged heightened promotional activity in categories, such as Fabric Care, Baby Care and Oral Care, particularly in the United States and Europe

    80% confidence
  • Management predicts a commodity cost headwind of $100 million after tax for fiscal 2026

    80% confidence
  • Management cautioned that tariff relief may be offset by pricing rollbacks if duties are reduced

    80% confidence
  • Our model estimates organic sales growth of 2% each for the Beauty and Health Care segments, and 4% for the Grooming segment

    80% confidence
  • The consensus mark for earnings has moved down by a penny in the past 30 days

    80% confidence
  • The consensus mark for PG's earnings is pegged at $1.87 per share, indicating a 0.5% decline from the year-ago quarter's actual

    80% confidence
  • We expect organic sales for both the Fabric & Home Care, and and Baby, Feminine & Family Care segments to be flat year over year

    80% confidence
  • We expect the core operating margin to fall by 80 bps in the quarter

    80% confidence
  • Procter & Gamble has an Earnings ESP of -0.82% and a Zacks Rank #4 (Sell)

    80% confidence
  • Management anticipates an after-tax headwind of about $250 million for fiscal 2026 due to modestly higher net interest expenses and an increased core effective tax rate compared with the previous year

    80% confidence
  • Our model predicts year-over-year organic sales growth of 1% for PG in the second quarter of fiscal 2026

    80% confidence
  • Management repeatedly emphasizing that sustainable growth will come from superior performance rather than price-led tactics

    80% confidence
  • Our model predicts a year-over-year core gross margin decline of 50 bps for the fiscal second quarter

    80% confidence
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com
Procter & Gamble Q2 Earnings Preview: Buy Now or Stay Cautious? — Source | Via News | es.VIA.NEWS